• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Study: Propeller’s digital asthma tech informs policy, improves health

April 13, 2018 By Sarah Faulkner

Propeller HealthResults from a large, real-world study of asthma patients found that digital health technology can improve patient outcomes and inform city-planning policy, Propeller Health touted this month.

The company teamed up with local government in Louisville, Kentucky and a nonprofit group to assess how environmental conditions can influence asthma symptoms using connected inhalers and a data-sharing platform.

In a study published this month in Health Affairs, Propeller showed that use of its platform cut the need for a rescue inhaler by 78% and boosted a user’s number of symptom-free days on average by 48%.

After collecting data regarding medication use, environmental conditions and outcomes, Propeller then shared that data with policymakers, who ultimately prescribed things like enhancing the local tree canopy, mitigating tree removal and zoning for air pollution emission buffers.

“AIR Louisville demonstrated the value of crowdsourced health data, influencing positive outcomes from an individual level up to the policy-making level,” Meredith Barrett, VP of research, said in prepared remarks. “We think the potential for this collaborative approach is huge, and Propeller is committed to using the data we collect across thousands of patients to better understand where, when and why respiratory symptoms happen so that we can help people live healthier lives.”

“Cities exist to provide citizens the opportunity to reach their full human potential — no matter their race, gender, sexual orientation, or ZIP code,” Louisville mayor Greg Fischer added. “This project is a citywide show of compassion for citizens who live here with asthma, and an example of how citizens can contribute their own data to help inform city decisions, and in so doing reignite their civic engagement.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Drug-Device Combinations, Featured, Research & Development, Respiratory Tagged With: Propeller Health

IN CASE YOU MISSED IT

  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS